[CLS] O
Models O
to O
predict O
intestinal O
absorption O
of O
therapeutic O
peptides O
and O
proteins O
. O
[SEP] O

[CLS] O
Antidepressant O
drugs O
are O
the O
preferred O
choice O
for O
treatment O
; O
however O
, O
treatment O
response O
is O
often O
variable O
. O
[SEP] O

[CLS] O
Similar O
trends O
were O
observed O
for O
remission O
although O
not O
statistically O
significant O
. O
[SEP] O

[CLS] O
Out O
of O
the O
117 O
individual O
persistent O
organic O
pollutants O
or O
metals O
assayed O
, O
46 O
could O
be O
detected O
in O
more O
than O
half O
of O
the O
placentas O
. O
[SEP] O

[CLS] O
The O
maternal O
body O
burden O
then O
was O
compared O
with O
its O
epidemiologically O
observed O
relationship O
with O
the O
IQ O
score O
. O
[SEP] O

[CLS] O
The O
order O
of O
concentration O
of O
the O
metals O
in O
the O
tissues O
is O
as O
follows O
: O
iron B
- O
blood O
> O
liver O
> O
testes O
; O
zinc B
- O
liver O
> O
blood O
> O
testes O
; O
lead O
- O
blood O
> O
liver O
> O
testes O
; O
copper B
- O
testes O
> O
liver O
> O
blood O
; O
nickel B
- O
liver O
> O
testes O
> O
blood O
. O
[SEP] O

[CLS] O
Volatile O
compound O
in O
cut O
and O
un O
- O
cut O
flowers O
of O
tetraploid O
Freesia O
hybrida O
. O
[SEP] O

[CLS] O
The O
studies O
also O
resulted O
in O
the O
identification O
of O
two O
known O
tetronic B
acids I
, O
viridicatic B
acid I
and O
terrestric B
acid I
, O
found O
in O
ethyl B
acetate I
and O
n B
- I
butanol I
extracts O
. O
[SEP] O

[CLS] O
OBP O
- O
401 O
- O
mediated O
GFP O
expression O
was O
significantly O
associated O
with O
CAR O
expression O
in O
tumor O
cells O
. O
[SEP] O

[CLS] O
To O
the O
best O
of O
our O
knowledge O
, O
this O
is O
the O
first O
study O
of O
the O
composition O
and O
antioxidant O
activity O
of O
essential O
oil O
from O
the O
T O
. O
catharinensis O
collected O
from O
Brazil O
. O
[SEP] O

[CLS] O
One O
hundred O
and O
fifty O
juveniles O
of O
O O
. O
niloticus O
were O
used O
for O
the O
toxicity O
study O
. O
[SEP] O

[CLS] O
A O
total O
of O
60 O
milk O
samples O
were O
collected O
from O
retail O
stores O
of O
five O
regions O
in O
June O
2011 O
. O
[SEP] O

[CLS] O
The O
functional O
selectivity O
of O
LY459477 B
was O
demonstrated O
by O
over O
640 O
- O
fold O
selectivity O
and O
the O
displacement O
binding O
selectivity O
was O
greater O
than O
320 O
- O
fold O
for O
all O
glutamate B
receptors O
except O
mGlu O
( O
6 O
) O
( O
~ O
230 O
- O
fold O
) O
. O
[SEP] O

[CLS] O
However O
, O
oral O
side O
effects O
and O
patient O
compliance O
is O
always O
a O
problem O
for O
schizophrenics O
. O
[SEP] O

[CLS] O
The O
" O
latent O
period O
" O
between O
brain O
injury O
and O
clinical O
epilepsy O
is O
widely O
regarded O
to O
be O
a O
seizure O
- O
free O
, O
pre O
- O
epileptic O
state O
during O
which O
a O
time O
- O
consuming O
cascade O
of O
molecular O
events O
and O
structural O
changes O
gradually O
mediates O
the O
process O
of O
" O
epileptogenesis O
. O
" O
The O
concept O
of O
the O
" O
latent O
period O
" O
as O
the O
duration O
of O
" O
epileptogenesis O
" O
implies O
that O
epilepsy O
is O
not O
an O
immediate O
result O
of O
brain O
injury O
, O
and O
that O
anti O
- O
epileptogenic O
strategies O
need O
to O
target O
delayed O
secondary O
mechanisms O
that O
develop O
sometime O
after O
an O
initial O
injury O
. O
[SEP] O

[CLS] O
Trans B
- I
3 I
( I
10 I
) I
- I
caren I
- I
4 I
- I
ol I
( O
22 O
. O
3 O
% O
) O
, O
artemisia B
ketone I
( O
18 O
. O
6 O
% O
) O
, O
1 B
, I
8 I
- I
cineole I
( O
14 O
. O
9 O
% O
) O
, O
delta B
- I
selinene I
( O
13 O
. O
0 O
% O
) O
and O
alpha B
- I
pinene I
( O
8 O
. O
2 O
% O
) O
were O
the O
major O
compounds O
. O
[SEP] O

[CLS] O
Moreover O
, O
RNA O
: O
DNA O
ratio O
, O
a O
proxy O
for O
protein O
synthetic O
activity O
, O
decreased O
in O
concert O
with O
increased O
TBARS O
, O
indicating O
a O
linkage O
between O
oxidative O
damage O
and O
fitness O
. O
[SEP] O

[CLS] O
The O
developed O
analytical O
method O
not O
only O
avoids O
the O
underestimation O
of O
total O
glucoraphanin B
content O
, O
but O
also O
provides O
a O
reduction O
in O
analysis O
time O
and O
good O
efficiency O
and O
sensitivity O
compared O
to O
with O
conventional O
HPLC O
methods O
. O
[SEP] O

[CLS] O
PIPs O
control O
associated O
PP1 O
by O
interference O
with O
substrate O
recruitment O
or O
access O
to O
the O
active O
site O
. O
[SEP] O

[CLS] O
Co O
- O
immunoprecipitation O
and O
mass O
spectrometric O
analysis O
identified O
alpha O
- O
actinin O
- O
4 O
( O
ACTN4 O
) O
as O
an O
MTBP O
- O
interacting O
protein O
. O
[SEP] O

[CLS] O
In O
this O
study O
, O
we O
report O
the O
isolation O
and O
identification O
of O
several O
compounds O
present O
in O
the O
polar O
fraction O
of O
Stachys O
germanica O
L O
. O
subsp O
. O
[SEP] O

[CLS] O
A O
3 O
. O
5 O
- O
fold O
increase O
in O
relative O
bioavailability O
was O
observed O
. O
[SEP] O

[CLS] O
Unexpectedly O
, O
both O
the O
mGluR O
( O
5 O
) O
specific O
agonist O
, O
CHPG B
, O
and O
the O
group O
II O
mGluR O
( O
mGlu O
( O
2 O
/ O
3 O
) O
) O
agonist O
, O
LY379268 B
( O
LY O
) O
, O
induced O
a O
TTX B
- O
insensitive O
outward O
current O
/ O
hyperpolarization O
. O
[SEP] O

